Učitavanje...
New Medications in the Treatment of Acute Migraine
Migraine is a common disorder affecting 12% of the US population. Use of triptans results in migraine pain relief within 2 hours in 16% to 51% of patients. However, due to their vasoconstrictive properties, triptans are contraindicated in patients with cardiovascular disease, peripheral vascular dis...
Spremljeno u:
| Izdano u: | Hosp Pharm |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628551/ https://ncbi.nlm.nih.gov/pubmed/31320771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578719844701 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|